Skip to content
ZBH Zimmer Biomet Holdings Inc NYSE
136.01 USD 0.53% +0.72
OPEN 134.69
DAY RANGE 136.35 - 134.22
52 WEEK RANGE 149.25 - 100.39
Interactive Brokers Logotype

Buy ZBH stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 28.5B
Enterprise value 32.8B
Trailing pe 63.55607
Forward pe 17.086683
Peg ratio 17.086683
Price to sales ttm 4.014607
Price to book mrq 2.3338537
Enterprise to revenue 4.619
Enterprise to ebitda 14.051


Fiscal year ends 2022-12-31
Most recent quarter 2023-03-31
Profit margin 0.06327
Operating margin 0.19864
Return on assets ttm 0.04118
Return on equity ttm 0.03728
Income statement
Revenue ttm 7.1B
Revenue per share ttm 33.903
Quarterly revenue growth 0.101
Gross profit ttm 4.9B
Ebitda 2.1B
Net income to common ttm 449.7M
Diluted eps ttm 2.14
Quarterly earnings growth yoy 15.373
Balance sheet
Total cash mrq 330.2M
Total cash per share mrq 1.583
Total debt mrq 6B
Total debt to equity mrq 49.191
Current ratio mrq 1.889
Book value per share mrq 58.277
Cash flow
Operating cash flow ttm 1.4B
Levered free cash flow ttm 1.4B

Stock statistics

Shares outstanding 209.8M
Float shares 208.3M
Avg 10 volume 2M
Avg 30 volume 1.6M
Shares short 2.7M
Short ratio 1.85
Short percent of shares outstanding 0.0165
Percent held by insiders 0.00103
Percent held by institutions 0.91108

Stock price summary

Fifty two week low 100.39
Fifty two week high 149.25
Fifty two week change 19.05
Beta 1.004222
Day 50 ma 133.4746
Day 200 ma 122.2816

Dividends and splits

Forward annual dividend rate 0.96
Forward annual dividend yield 0.0074
Trailing annual dividend rate 0.96
Trailing annual dividend yield 0.0070958682
5 year average dividend yield 0.74
Payout ratio 0.4486
Dividend date 2023-07-31
Ex dividend date 2023-06-23
Last split factor 103-for-100 split
Last split date 2022-03-01

Zimmer Biomet (ZBH) company profile

Zimmer Biomet Inc. (NYSE: ZBH) designs, manufacture, and markets orthopedic reconstructive products. The products are sports medicine, biologics, extremities and trauma, office-based technologies, spine, craniomaxillofacial and thoracic products, dental implants, and related surgical products. The company’s operations are divided into the Americas and Global Businesses, Europe, Middle East, Africa, and Asia Pacific.